- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06210789
Periodontal Plastic Reconstruction of Soft Tissue Dehiscences After the Removal of Localized Gingival Enlargements
January 8, 2024 updated by: Balint Molnar, Semmelweis University
Periodontal Plastic Surgical Approaches to Correct Recession and Lack of Keratinized Tissue After Elimination of Localized Gingival Enlargements - a Case Series
Non-inflammatory recessions and Miller class I-II-III.
mucogingival defects after elimination of localized gingival enlargements are frequently encountered challenges in the daily practice.
In Miller class II-III.
recessions the lack of keratinized tissues often compromise the maintenance a proper oral hygiene, this can cause inflammation, which can result in further periodontal attachment loss.
In the literature there are some approaches that aim at widening of keratinized tissues and root coverage at the same time, such as the subperiosteal envelope technique (SET) (Allen 1994) combined with a subepithelial connective tissue graft (SCTG) or a partially epithelialized connective tissue graft (PE-SCTG) (Stimmelmayr 2011).
In the eradication of localized gingival enlargement postoperative complications following surgical removal, such as recurrence and subsequent gingival recessions as well as loss of keratinized tissues are commonly observed.
Nevertheless, a state of the art comprehensive treatment approach has not been reported yet to overcome the above mentioned sequels.
The aim of this study is to present a periodontal plastic surgical approach to definitively eliminate localized gingiva enlargements and to simultaneously correct consecutive Miller class I II-III.
recessions, esthetic disturbances.
(Ethical committee permission number: SE RKEB: 185/2020.)
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bálint Molnár
- Phone Number: +36 1 318 5222
- Email: molbal81@gmail.com
Study Contact Backup
- Name: Andrea Dobos
- Phone Number: +36309532140
- Email: andobos@ucm.es
Study Locations
-
-
-
Budapest, Hungary, 1088
- Recruiting
- Semmelweis University, Faculty of Dentistry
-
Contact:
- Andrea Dobos
- Phone Number: +36309532140
- Email: andobos@ucm.es
-
Contact:
- Bálint Molnár
- Phone Number: +3613185222
- Email: molbal81@gmail.com
-
Sub-Investigator:
- Andrea Dobos, DMD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- patients older than 18 years
- systematically healthy patients
- localized gingival enlargement is present that involves maximum 3 teeth
Exclusion Criteria:
- pregnant women
- medication intake that can potentially affect the oral mucosa and its healing
- heavy smokers (>=15)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Surgical treatment
Surgical excision and periodontal reconstruction according to the remaining amount of keratinized gingiva
|
Periodontal plastic reconstruction of the subsequent soft tissue dehiscence after the surgical excision of the localized gingival enlargement
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recurrence
Time Frame: 3 months, 6 months
|
If there is recurrence after the proper elimination of the enlargement and the one-staged reconstruction
|
3 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Keratinized Gingiva Height
Time Frame: 1 month, 3 months, 6 months
|
The height of the remaining keratinized gingiva
|
1 month, 3 months, 6 months
|
Gingival Recession
Time Frame: 1 month, 3 months, 6 months
|
The subsequent gingiva recession that remains after the elimination of the enlargement and the reconstruction of the soft tissue
|
1 month, 3 months, 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bálint Molnár, Semmelweis University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 5, 2024
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
January 8, 2024
First Submitted That Met QC Criteria
January 8, 2024
First Posted (Actual)
January 18, 2024
Study Record Updates
Last Update Posted (Actual)
January 18, 2024
Last Update Submitted That Met QC Criteria
January 8, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Epulis
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Recurrence
-
Portuguese Oncology Institute, CoimbraCompletedColorectal Cancer | Recurrence, Local NeoplasmPortugal
-
Chinese PLA General HospitalRecruitingHCC | Recurrence TumorChina
-
Paracelsus Medical UniversityHeinrich-Heine University, Duesseldorf; Poznan University of Medical Sciences; University Hospital of Ferrara and other collaboratorsCompletedToxicity | Local Neoplasm RecurrenceAustria
-
General Hospital GroeningeUniversitaire Ziekenhuizen KU Leuven; Jessa Hospital; University Hospital, Ghent and other collaboratorsNot yet recruiting
-
Dallas VA Medical CenterTerminatedSolid Tumors | Cancer RecurrenceUnited States
-
The University of Hong KongNot yet recruitingCancer | Fear of Cancer Recurrence
-
RottapharmTerminatedHCV Recurrence After Liver Transplantation
-
The University of Hong KongHealth and Medical Research FundNot yet recruitingCancer | Fear of Cancer Recurrence
-
German Centre for Assessment and Evaluation of...Not yet recruitingComplication | Continence | Potency | Biochemical RecurrenceGermany
-
The University of Hong KongHealth and Medical Research FundNot yet recruitingCancer | Fear of Cancer Recurrence | Psychooncology
Clinical Trials on Surgical excision
-
University Hospital Inselspital, BerneCompleted
-
Sohag UniversityRecruitingSpinal Cord TumorEgypt
-
Lawson Health Research InstituteNot yet recruitingBreast Fibroadenoma | Lobular Carcinoma in Situ | Atypical Ductal Hyperplasia | Phyllodes Breast Tumor | Atypical Lobular Hyperplasia | Flat Epithelial Atypia | Phyllodes; Fibroadenoma | Radial Scar | Breast Papilloma | Complex Sclerosing Papillary Lesion of the Breast
-
Sohag UniversityActive, not recruiting
-
Peking Union Medical College HospitalCompleted
-
Stanford UniversityRecruitingPilonidal DiseaseUnited States
-
Assiut UniversityUnknownManagement of Intracranial Cavernous Hemangioma
-
Kasr El Aini HospitalUnknownNeurocognitive Outcome Assesment in Patients With Perioptic Meningiomas
-
Domain Surgical, Inc.Withdrawn
-
Shanghai Minimally Invasive Surgery CenterUnknownRectal Cancer | Surgery